• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性呼吸道乳头状瘤病相关流行病学因素的最新综述。

An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis.

作者信息

Welschmeyer Alexandra, Berke Gerald S

机构信息

Georgetown University School of Medicine Washington District of Columbia USA.

Department of Head and Neck Surgery Ronald Reagan UCLA Medical Center Los Angeles California USA.

出版信息

Laryngoscope Investig Otolaryngol. 2021 Jan 28;6(2):226-233. doi: 10.1002/lio2.521. eCollection 2021 Apr.

DOI:10.1002/lio2.521
PMID:33869755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8035934/
Abstract

OBJECTIVES

To identify studies evaluating the epidemiology of recurrent respiratory papillomatosis (RRP), including patient demographics, human papillomavirus (HPV) immunology, clinical course, surgical and medical treatments, and psychosocial factors.

METHODS

A systematic literature search through PubMed was performed to identify studies evaluating the epidemiological factors associated with RRP. All studies were screened through a priori selection criteria using the titles and abstracts.

RESULTS

A total of 208 studies were identified, of which 54 met eligibility criteria and were included in the review.

CONCLUSIONS

RRP is a rare disease most commonly caused by HPV 6 and 11. It is characterized by recurring benign papillomatous lesions in the respiratory tract, particularly the larynx. Existing evidence about disease risk factors is limited but includes both maternal HPV infection and patient smoking and sexual behaviors. Disease management involves a combination of routine surgical and medical treatment. Surgical techniques include CO-laser, sharp dissection, coblation, microdebridement, and photoangiolytic laser. Medical treatments which have been found to facilitate disease control off-label include interferon-alpha (IFN-α), indole-3-carbinol, acyclovir, bevacizumab, retinoids, and the Gardasil and mumps vaccines. Many patients suffer from additional psychosocial challenges related to their diagnosis. Current disease knowledge remains limited, and more robust controlled trials about risk factors, medical therapies, and surgical options are needed.

LEVEL OF EVIDENCE

摘要

目的

确定评估复发性呼吸道乳头状瘤病(RRP)流行病学的研究,包括患者人口统计学、人乳头瘤病毒(HPV)免疫学、临床病程、手术和药物治疗以及社会心理因素。

方法

通过PubMed进行系统的文献检索,以确定评估与RRP相关的流行病学因素的研究。所有研究均通过使用标题和摘要的先验选择标准进行筛选。

结果

共识别出208项研究,其中54项符合纳入标准并被纳入综述。

结论

RRP是一种罕见疾病,最常见由HPV 6和11引起。其特征是呼吸道尤其是喉部反复出现良性乳头状瘤病变。关于疾病危险因素的现有证据有限,但包括母亲HPV感染以及患者吸烟和性行为。疾病管理涉及常规手术和药物治疗的联合。手术技术包括CO2激光、锐性剥离、低温等离子消融、显微清创和光动力激光。已发现可在标签外促进疾病控制的药物治疗包括α干扰素(IFN-α)、吲哚-3-甲醇、阿昔洛韦、贝伐单抗、维甲酸以及加德西疫苗和腮腺炎疫苗。许多患者因诊断而面临额外的社会心理挑战。目前对该疾病的了解仍然有限,需要更多关于危险因素、药物治疗和手术选择的有力对照试验。

证据级别

5级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/8035934/d761a10b75ce/LIO2-6-226-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/8035934/d761a10b75ce/LIO2-6-226-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd0/8035934/d761a10b75ce/LIO2-6-226-g002.jpg

相似文献

1
An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病相关流行病学因素的最新综述。
Laryngoscope Investig Otolaryngol. 2021 Jan 28;6(2):226-233. doi: 10.1002/lio2.521. eCollection 2021 Apr.
2
Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.复发性喉乳头状瘤:多模态治疗策略。文献回顾和多中心回顾性研究。
Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S111-S122. doi: 10.14639/0392-100X-suppl.1-43-2023-14.
3
Recurrent respiratory papillomatosis: A 2020 perspective.复发性呼吸道乳头状瘤病:2020年视角
Laryngoscope Investig Otolaryngol. 2021 Mar 13;6(2):340-345. doi: 10.1002/lio2.545. eCollection 2021 Apr.
4
Current and future management of recurrent respiratory papillomatosis.复发性呼吸道乳头状瘤病的当前及未来管理
Laryngoscope Investig Otolaryngol. 2018 Jan 14;3(1):22-34. doi: 10.1002/lio2.132. eCollection 2018 Feb.
5
Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.成人复发性呼吸道乳头状瘤病:疾病发病机制综述及对患者咨询的意义
JAMA Otolaryngol Head Neck Surg. 2015 Jan;141(1):78-83. doi: 10.1001/jamaoto.2014.2826.
6
Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update.复发性呼吸道乳头瘤病(RRP)的药物治疗:治疗更新。
Expert Opin Pharmacother. 2021 Oct;22(14):1901-1908. doi: 10.1080/14656566.2021.1935870. Epub 2021 Jul 5.
7
Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.复发性呼吸道乳头瘤病中低危型 HPV 的免疫耐受。
Clin Exp Immunol. 2020 Feb;199(2):131-142. doi: 10.1111/cei.13387. Epub 2019 Oct 31.
8
Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.复发性呼吸道乳头瘤病患者接种人乳头瘤病毒疫苗的结局:一项非随机临床试验。
JAMA Otolaryngol Head Neck Surg. 2022 Jul 1;148(7):654-661. doi: 10.1001/jamaoto.2022.1190.
9
Airway Papillomatosis: New Treatments for an Old Challenge.气道乳头状瘤病:应对旧挑战的新疗法。
Front Pediatr. 2019 Sep 18;7:383. doi: 10.3389/fped.2019.00383. eCollection 2019.
10
[Recurrent respiratory papillomatosis: indication for HPV vaccination?].[复发性呼吸道乳头状瘤病:HPV疫苗接种的指征?]
Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S100-2. doi: 10.1055/s-0029-1220219. Epub 2009 Apr 7.

引用本文的文献

1
Recurrent respiratory papillomatosis: role of bevacizumab and HPV vaccination. A literature review with case presentations.复发性呼吸道乳头状瘤病:贝伐单抗和人乳头瘤病毒疫苗接种的作用。附病例报告的文献综述。
Radiol Oncol. 2025 Feb 27;59(1):23-30. doi: 10.2478/raon-2025-0010. eCollection 2025 Mar 1.
2
"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis".复发性呼吸道乳头状瘤病的流行病学、临床、经济和人文负担的系统文献综述
Respir Res. 2024 Dec 18;25(1):430. doi: 10.1186/s12931-024-03057-w.
3
Genomic diversity of HPV6 and HPV11 in recurrent respiratory papillomatosis: Association with malignant transformation in the lungs and clinical outcomes.

本文引用的文献

1
Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.复发性呼吸道乳头瘤病中低危型 HPV 的免疫耐受。
Clin Exp Immunol. 2020 Feb;199(2):131-142. doi: 10.1111/cei.13387. Epub 2019 Oct 31.
2
Efficacy of microsurgery in combined with topical-PDT in treating recurrent respiratory papillomatosis: compare JORRP with AORRP.显微手术联合局部光动力疗法治疗复发性呼吸道乳头状瘤病的疗效:比较青少年复发性呼吸道乳头状瘤病与成人复发性呼吸道乳头状瘤病。
Acta Otolaryngol. 2019 Dec;139(12):1133-1139. doi: 10.1080/00016489.2019.1667530. Epub 2019 Sep 26.
3
High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis.
复发性呼吸道乳头状瘤病中HPV6和HPV11的基因组多样性:与肺部恶性转化及临床结局的关联
Tumour Virus Res. 2024 Dec;18:200294. doi: 10.1016/j.tvr.2024.200294. Epub 2024 Oct 29.
4
Characterization of HPV6/11-reactive T-cell subsets in papillomas of patients with juvenile-onset recurrent respiratory papillomatosis and identification of HPV11 E7-specific candidate TCR clonotypes.鉴定青少年复发性呼吸道乳头瘤病患者的乳头瘤中 HPV6/11 反应性 T 细胞亚群,并鉴定 HPV11 E7 特异性候选 TCR 克隆型。
J Virol. 2024 Oct 22;98(10):e0067724. doi: 10.1128/jvi.00677-24. Epub 2024 Sep 11.
5
Remission of HPV-Related Diseases by Antivirals for Herpesvirus: Clinical Cases and a Literature Review.抗病毒药物治疗疱疹病毒相关疾病的缓解:临床病例及文献复习。
Viruses. 2024 May 10;16(5):756. doi: 10.3390/v16050756.
6
The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.喉在免疫功能正常的小鼠中免受继发性和垂直型人乳头瘤病毒感染的保护。
Laryngoscope. 2024 May;134(5):2322-2330. doi: 10.1002/lary.31228. Epub 2023 Dec 12.
7
HPV Vaccination: An Underused Strategy for the Prevention of Cancer.HPV 疫苗接种:预防癌症的未充分利用策略。
Curr Oncol. 2022 May 23;29(5):3780-3792. doi: 10.3390/curroncol29050303.
8
HPV and Recurrent Respiratory Papillomatosis: A Brief Review.人乳头瘤病毒与复发性呼吸道乳头状瘤病:简要综述
Life (Basel). 2021 Nov 22;11(11):1279. doi: 10.3390/life11111279.
9
Transcriptomic Landscape of Gene Expression Profiles and Pathways in Juvenile-Onset Recurrent Respiratory Papillomatosis Tumor Tissues and Human Papillomavirus 6 and 11 E6- and E7-Overexpressing Head and Neck Squamous Cell Carcinoma Cell Lines.转录组水平下基因表达谱和通路在青少年复发性呼吸道乳头瘤病肿瘤组织及人乳头瘤病毒 6 型和 11 型 E6 和 E7 过表达的头颈部鳞状细胞癌细胞系中的特征。
J Virol. 2022 Jan 26;96(2):e0134221. doi: 10.1128/JVI.01342-21. Epub 2021 Oct 20.
高通量筛选确定了用于治疗复发性呼吸道乳头状瘤病的候选药物。
Papillomavirus Res. 2019 Dec;8:100181. doi: 10.1016/j.pvr.2019.100181. Epub 2019 Aug 22.
4
Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis.发病年龄与复发性呼吸道乳头瘤病的临床病程密切相关,而 HPV 类型则无明显相关性。
PLoS One. 2019 Jun 13;14(6):e0216697. doi: 10.1371/journal.pone.0216697. eCollection 2019.
5
Laryngeal distribution of adult-onset recurrent respiratory papillomatosis: A longitudinal study.成人复发性呼吸道乳头瘤病的喉分布:一项纵向研究。
Laryngoscope. 2019 Sep;129(9):1993-1997. doi: 10.1002/lary.27694. Epub 2019 May 6.
6
Postoperative Systemic Acyclovir in Juvenile-Onset Recurrent Respiratory Papillomatosis: The Outcome.青少年复发性呼吸道乳头状瘤病术后全身使用阿昔洛韦:结果
Ear Nose Throat J. 2019 Jan;98(1):28-31. doi: 10.1177/0145561318823311. Epub 2019 Jan 30.
7
Management of laryngeal papillomatosis using coblation: another option of surgical intervention.使用低温等离子消融术治疗喉乳头状瘤病:手术干预的另一种选择。
Eur Arch Otorhinolaryngol. 2019 Mar;276(3):793-800. doi: 10.1007/s00405-019-05354-3. Epub 2019 Feb 23.
8
Histopathological features of juvenile-onset laryngeal papillomatosis related to severity.与严重程度相关的青少年发病型喉乳头状瘤的组织病理学特征。
Head Neck. 2019 May;41(5):1412-1417. doi: 10.1002/hed.25602. Epub 2019 Jan 8.
9
Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.常规人乳头瘤病毒疫苗接种在复发性呼吸道乳头状瘤病管理中的应用
Ann Otol Rhinol Laryngol. 2019 Apr;128(4):309-315. doi: 10.1177/0003489418821695. Epub 2018 Dec 29.
10
Prevalence, clinical presentations, associated risk factors and recurrence of laryngeal papillomatosis among inpatients attended at a Tertiary Hospital in Northern zone Tanzania.坦桑尼亚北部地区一家三级医院住院患者中喉乳头状瘤病的患病率、临床表现、相关危险因素及复发情况
Pan Afr Med J. 2018 Jul 16;30:209. doi: 10.11604/pamj.2018.30.209.11211. eCollection 2018.